Year |
Citation |
Score |
2023 |
Nelson L, Ing SW, Rubin MR, Ma J, Martin S, Sen R, Ayodele O. Psychometric Analysis of the Patient-Reported Hypoparathyroidism Symptom Diary Symptom Subscale Using Data from Two Clinical Trials. Patient Related Outcome Measures. 14: 355-367. PMID 38046664 DOI: 10.2147/PROM.S414794 |
0.354 |
|
2021 |
Han JK, Bachert C, Lee SE, Hopkins C, Heffler E, Hellings PW, Peters AT, Kamat S, Whalley D, Qin S, Nelson L, Siddiqui S, Khan AH, Li Y, Mannent LP, et al. Estimating Clinically Meaningful Change of Efficacy Outcomes in Inadequately Controlled Chronic Rhinosinusitis with Nasal Polyposis. The Laryngoscope. PMID 34850966 DOI: 10.1002/lary.29888 |
0.314 |
|
2019 |
Pariser DM, Simpson EL, Gadkari A, Bieber T, Margolis DJ, Brown M, Nelson L, Mahajan P, Reaney M, Guillemin I, Mallya UG, Eckert L. Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT). Current Medical Research and Opinion. 1. PMID 31778083 DOI: 10.1080/03007995.2019.1699516 |
0.378 |
|
2019 |
Simpson E, Eckert L, Gadkari A, Mallya UG, Yang M, Nelson L, Brown M, Reaney M, Mahajan P, Guillemin I, Boguniewicz M, Pariser D. Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis. Bmc Dermatology. 19: 15. PMID 31690295 DOI: 10.1186/S12895-019-0095-3 |
0.395 |
|
2019 |
Simpson EL, de Bruin-Weller M, Eckert L, Whalley D, Guillemin I, Reaney M, Chen Z, Nelson L, Qin S, Bansal A, Gadkari A. Responder Threshold for Patient-Oriented Eczema Measure (POEM) and Children's Dermatology Life Quality Index (CDLQI) in Adolescents with Atopic Dermatitis. Dermatology and Therapy. PMID 31641952 DOI: 10.1007/S13555-019-00333-2 |
0.341 |
|
2019 |
Nelson LM, DiBenedetti D, Pariser DM, Glaser DA, Hebert AA, Hofland H, Drew J, Ingolia D, Gillard KK, Fehnel S. Development and validation of the Axillary Sweating Daily Diary: a patient-reported outcome measure to assess axillary sweating severity. Journal of Patient-Reported Outcomes. 3: 59. PMID 31486951 DOI: 10.1186/S41687-019-0148-8 |
0.448 |
|
2019 |
Lewis EF, Coles TM, Lewis S, Nelson LM, Barrett A, Romano CD, Stull DE, Turner SJ, Chang CG. Development, psychometric evaluation, and initial feasibility assessment of a symptom tracker for use by patients with heart failure (HFaST). Journal of Patient-Reported Outcomes. 3: 26. PMID 31049726 DOI: 10.1186/S41687-019-0113-6 |
0.369 |
|
2019 |
Fehnel S, Fiedorek FT, Nelson L, DiBenedetti D, Spence S, Carson RT. Development and psychometric evaluation of the Diabetic Gastroparesis Symptom Severity Diary. Clinical and Experimental Gastroenterology. 12: 93-103. PMID 30863134 DOI: 10.2147/Ceg.S184016 |
0.395 |
|
2019 |
Coles T, Chen K, Nelson L, Harris N, Vera-Llonch M, Krasner A, Martin S. Psychometric evaluation of the hypoparathyroidism symptom diary. Patient Related Outcome Measures. 10: 25-36. PMID 30774490 DOI: 10.2147/Prom.S179310 |
0.379 |
|
2019 |
Yosipovitch G, Reaney M, Mastey V, Eckert L, Abbé A, Nelson L, Clark M, Williams N, Chen Z, Ardeleanu M, Akinlade B, Graham NMH, Pirozzi G, Staudinger H, Plaum S, et al. Peak Pruritus Numerical Rating Scale: Psychometric Validation and Responder Definition for Assessing Itch in Moderate-To-Severe Atopic Dermatitis. The British Journal of Dermatology. PMID 30729499 DOI: 10.1111/Bjd.17744 |
0.367 |
|
2018 |
Qin S, Nelson L, McLeod L, Eremenco S, Coons SJ. Assessing test-retest reliability of patient-reported outcome measures using intraclass correlation coefficients: recommendations for selecting and documenting the analytical formula. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. PMID 30547346 DOI: 10.1007/S11136-018-2076-0 |
0.366 |
|
2018 |
Odom D, McLeod L, Sherif B, Nelson L, McSorley D. Longitudinal Modeling Approaches to Assess the Association Between Changes in 2 Clinical Outcome Assessments. Therapeutic Innovation & Regulatory Science. 52: 306-312. PMID 29714541 DOI: 10.1177/2168479017731584 |
0.375 |
|
2018 |
Donohue JF, Bollu VK, Stull DE, Nelson LM, Williams VS, Stensland MD, Hanania NA. Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial. International Journal of Chronic Obstructive Pulmonary Disease. 13: 499-508. PMID 29440887 DOI: 10.2147/Copd.S141729 |
0.381 |
|
2017 |
Davis KH, Su J, González JM, Trudeau JJ, Nelson LM, Hauber B, Hollis KA. Quantifying the importance of inhaler attributes corresponding to items in the patient satisfaction and preference questionnaire in patients using Combivent Respimat. Health and Quality of Life Outcomes. 15: 201. PMID 29037248 DOI: 10.1186/S12955-017-0780-Z |
0.313 |
|
2017 |
Fehnel S, Nelson L, DiBenedetti D, Carson RT, Spence SC, Fiedorek FT. Development and Psychometric Evaluation of the Diabetic Gastroparesis Symptom Severity Diary Gastroenterology. 152. DOI: 10.1016/S0016-5085(17)31904-2 |
0.324 |
|
2016 |
Donohue JF, Ganapathy V, Bollu V, Stensland MD, Nelson LM. Health Status of Patients with Moderate to Severe COPD after Treatment with Nebulized Arformoterol Tartrate or Placebo for 1 Year. Clinical Therapeutics. PMID 28011247 DOI: 10.1016/J.Clinthera.2016.11.021 |
0.358 |
|
2016 |
Williams V, François C, Danchenko N, Nelson L, Williams N, Yarr S, DiBenedetti D, Lançon C. Psychometric validation of the depression and family functioning scale. Current Medical Research and Opinion. 1-12. PMID 26700415 DOI: 10.1185/03007995.2015.1135111 |
0.366 |
|
2015 |
Williams V, McLeod L, Nelson L. Advances in the Evaluation of Longitudinal Construct Validity of Clinical Outcome Assessments. Therapeutic Innovation & Regulatory Science. 49: 805-812. PMID 30222389 DOI: 10.1177/2168479015609103 |
0.305 |
|
2015 |
Strober B, Zhao Y, Tran MH, Gnanasakthy A, Nyirady J, Papavassils C, Nelson LM, McLeod LD, Mordin M, Gottlieb AB, Elewski BE, Lebwohl M. Psychometric validation of the Psoriasis Symptom Diary using Phase III study data from patients with chronic plaque psoriasis. International Journal of Dermatology. PMID 26518255 DOI: 10.1111/Ijd.13117 |
0.441 |
|
2015 |
Camilleri M, Lembo AJ, Lavins BJ, MacDougall JE, Carson RT, Williams VS, Nelson LM, Shiff SJ, Currie MG, Kurtz CB, Johnston JM. Comparison of adequate relief with symptom, global, and responder endpoints in linaclotide phase 3 trials in IBS-C. United European Gastroenterology Journal. 3: 53-62. PMID 25653859 DOI: 10.1177/2050640614555946 |
0.371 |
|
2015 |
Williams V, McLeod L, Nelson L. Advances in the Evaluation of Longitudinal Construct Validity of Clinical Outcome Assessments Therapeutic Innovation and Regulatory Science. 49: 805-812. DOI: 10.1177/2168479015609103 |
0.403 |
|
2015 |
Odom D, McLeod L, Sherif B, Nelson L. Methods To Assess The Association Of Patient-Reported Outcomes And Clinical Endpoints Value in Health. 18: A6. DOI: 10.1016/J.Jval.2015.03.042 |
0.391 |
|
2014 |
Coles TM, Chen WH, Nelson LM, Williams V, McLeod LD. Current Sample Size Practices in the Psychometric Evaluation of Patient-Reported Outcomes for Use in Clinical Trials. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 17: A571. PMID 27201904 DOI: 10.1016/J.Jval.2014.08.1909 |
0.376 |
|
2014 |
Nelson LM, Williams VS, Fehnel SE, Carson RT, MacDougall J, Baird MJ, Tourkodimitris S, Kurtz CB, Johnston JM. Psychometric validation of patient-reported outcome measures assessing chronic constipation. Clinical and Experimental Gastroenterology. 7: 385-94. PMID 25298737 DOI: 10.2147/Ceg.S64713 |
0.47 |
|
2014 |
Williams VS, Nelson LM, Fehnel SE, MacDougall J, Carson RT, Tourkodimitris S, Kurtz C, Baird MJ, Johnston JM. Psychometric validation of symptom severity measures in irritable bowel syndrome with constipation. Alimentary Pharmacology & Therapeutics. 40: 298-308. PMID 24943204 DOI: 10.1111/Apt.12830 |
0.464 |
|
2014 |
Webb SM, Ware JE, Forsythe A, Yang M, Badia X, Nelson LM, Signorovitch JE, McLeod L, Maldonado M, Zgliczynski W, de Block C, Portocarrero-Ortiz L, Gadelha M. Treatment effectiveness of pasireotide on health-related quality of life in patients with Cushing's disease. European Journal of Endocrinology / European Federation of Endocrine Societies. 171: 89-98. PMID 24760537 DOI: 10.1530/Eje-13-1013 |
0.382 |
|
2014 |
Chen WH, McLeod LD, Nelson LM, Williams VS, Fehnel SE. Quantitative challenges facing patient-centered outcomes research. Expert Review of Pharmacoeconomics & Outcomes Research. 14: 379-86. PMID 24758551 DOI: 10.1586/14737167.2014.912133 |
0.31 |
|
2014 |
Bollu V, Nelson LM, Williams VS, Stensland MD, Stull DE. Symptom Response Profiles For Patients With Chronic Obstructive Pulmonary Disease Initiating Nebulized Arformoterol Tartrate Or Placebo Value in Health. 17. DOI: 10.1016/J.Jval.2014.03.995 |
0.332 |
|
2014 |
Strober B, Zhao Y, Tran M, Gnanasakthy A, Nelson L, McLeod L, Mordin M, Gottlieb A, Elewski B, Lebwohl M. Psychometric Evaluation Of The Psoriasis Symptom Diary Using Phase 3 Trial Data Value in Health. 17: A288. DOI: 10.1016/J.Jval.2014.03.1676 |
0.39 |
|
2013 |
Nelson LM, Forsythe A, McLeod L, Pulgar S, Maldonado M, Coles T, Zhang Y, Webb SM, Badia X. Psychometric evaluation of the Cushing's Quality-of-Life questionnaire. The Patient. 6: 113-24. PMID 23575965 DOI: 10.1007/S40271-013-0012-5 |
0.326 |
|
2013 |
Macdougall JE, Johnston JM, Lavins BJ, Nelson LM, Williams VS, Carson RT, Shiff SJ, Shi K, Kurtz CB, Baird MJ, Currie MG, Lembo AJ. An evaluation of the FDA responder endpoint for IBS-C clinical trials: analysis of data from linaclotide Phase 3 clinical trials. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 25: 481-6. PMID 23384406 DOI: 10.1111/Nmo.12089 |
0.418 |
|
2012 |
Engelhart L, Nelson L, Lewis S, Mordin M, Demuro-Mercon C, Uddin S, McLeod L, Cole B, Farr J. Validation of the Knee Injury and Osteoarthritis Outcome Score subscales for patients with articular cartilage lesions of the knee. The American Journal of Sports Medicine. 40: 2264-72. PMID 22962288 DOI: 10.1177/0363546512457646 |
0.389 |
|
2012 |
Carson R, Nelson L, Williams V, Fehnel S, Tourkodimitris S, Baird M, Johnston J. Psychometric Evaluation of Patient-Reported Outcome Measures for Assessing IBS-C Symptom Severity and Change: Results From 2 Randomized, Double-Blind, Placebo-Controlled Phase 3 Trials of Linaclotide: 1479 The American Journal of Gastroenterology. 107. DOI: 10.14309/00000434-201210001-01479 |
0.476 |
|
2012 |
Nelson L, Williams V, Fehnel S, Tourkodimitris S, Baird M, Carson R, Johnston J. Psychometric Evaluation of Patient-Reported Outcome Measures for Assessing Chronic Constipation Symptom Severity and Change: Results From Phase 2b and Phase 3 Trials of Linaclotide: 1472 The American Journal of Gastroenterology. 107. DOI: 10.14309/00000434-201210001-01472 |
0.448 |
|
2012 |
Williams V, Nelson L, Carson R, Baird M, Coon C, Fehnel S, Johnston J. Factor Analyses of Patient-Reported Outcome Measures in Irritable Bowel Syndrome With Constipation: Results From 2 Randomized, Double-blind, Placebo-Controlled Phase 3 Trials of Linaclotide: 1471 The American Journal of Gastroenterology. 107. DOI: 10.14309/00000434-201210001-01471 |
0.405 |
|
2012 |
Nelson L, Williams V, Carson R, Baird M, Coon C, Fehnel S, Johnston J. Factor Analyses of Chronic Constipation Patient-Reported Outcome Measures: Results From Phase 2b and Phase 3 Trials of Linaclotide: 1460 The American Journal of Gastroenterology. 107. DOI: 10.14309/00000434-201210001-01460 |
0.366 |
|
2012 |
Spiegel BM, Locke GR, Kurtz CB, Williams V, Nelson LM, Carson R, Jia XD, Currie MG, MacDougall JE, Schneier H, Johnston JM. Sa1094 Developing Benchmarks for Clinically Meaningful Change for IBS-C Symptoms Using Data From Two Phase 3 Trials of Linaclotide Gastroenterology. 142. DOI: 10.1016/S0016-5085(12)60802-6 |
0.379 |
|
2012 |
Badia X, Forsythe A, Nelson L, Coles T, Mcleod L, Webb S. PDB63 Improvements in Health-Related Quality of Life in Acromegaly With Pasireotide LAR and Octreotide LAR: Results From a Large, Randomized, Double-Blind Phase III Trial Value in Health. 15: A505. DOI: 10.1016/J.Jval.2012.08.1706 |
0.317 |
|
2011 |
Dalal AA, Nelson L, Gilligan T, McLeod L, Lewis S, DeMuro-Mercon C. Evaluating patient-reported outcome measurement comparability between paper and alternate versions, using the lung function questionnaire as an example. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 14: 712-20. PMID 21839410 DOI: 10.1016/J.Jval.2010.12.007 |
0.404 |
|
2011 |
Bell C, McLeod LD, Nelson LM, Fehnel SE, Zografos LJ, Bowers B. Development and psychometric evaluation of a new patient-reported outcome instrument measuring the functional impact of insomnia. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 20: 1457-68. PMID 21505882 DOI: 10.1007/S11136-011-9885-8 |
0.396 |
|
2011 |
Dalal A, Nelson L, Gilligan T, McLeod L, Lewis S, DeMuro C. PRS46 MEASUREMENT COMPARABILITY BETWEEN PAPER AND ALTERNATE VERSIONS: RECOMMENDED ASSESSMENT STEPS USING THE LUNG FUNCTION QUESTIONNAIRE AS AN EXAMPLE Value in Health. 14: A145. DOI: 10.1016/J.Jval.2011.02.807 |
0.302 |
|
2010 |
Dalal AA, Demuro-Mercon C, Lewis S, Nelson L, Gilligan T, McLeod L. Validation of alternate modes of administration of the lung function questionnaire (LFQ) in subjects with smoking history. International Journal of Chronic Obstructive Pulmonary Disease. 5: 425-34. PMID 21191437 DOI: 10.2147/Copd.S13900 |
0.326 |
|
2010 |
Lee LJ, Fahrbach JL, Nelson LM, McLeod LD, Martin SA, Sun P, Weinstock RS. Effects of insulin initiation on patient-reported outcomes in patients with type 2 diabetes: results from the durable trial. Diabetes Research and Clinical Practice. 89: 157-66. PMID 20537750 DOI: 10.1016/J.Diabres.2010.04.002 |
0.348 |
|
2009 |
Carson R, Williams V, Nelson L, MacDougall J, Johnston J. Psychometric Evaluation of Patient-Reported Outcome Measures for Assessing IBS-C Symptom Severity and Global Change: Results From a Phase 2b Study of Linaclotide: 1113 The American Journal of Gastroenterology. 104. DOI: 10.14309/00000434-200910003-01113 |
0.446 |
|
Show low-probability matches. |